Global /Germany /Healthcare /Medical Care Facilities /NN6

NanoRepro AG

NN6

• XETRA: NN6 • Delayed

1.53EUR -2.6%

1.78 USD

As of 5 June 2026, NanoRepro AG has a market cap of $22.97M USD, ranking #36153 globally and #365 in Germany. It ranks #3248 in the Healthcare sector, and #396 in the Medical Care Facilities industry.

Global Rank

36153

Country Rank

365

Sector Rank

3248

Industry Rank

396

Key Stats

Market Cap

$22.97MUSD

19.8M EUR

Enterprise Value

$14.53MUSD

12.51M EUR

Revenue (TTM)

$5.99MUSD

5.17M EUR

EBITDA (TTM)

-$2.63MUSD

-2.27M EUR

Net Income (TTM)

-$2.0MUSD

-1.72M EUR

EBITDA Margin

-44%

Profit Margin

-33%

PS Ratio

3.8

PB Ratio

0.5

Company Profile

Country (HQ)

Germany

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Lisa Jungst open_in_new

Employees

Founded

2006

Website

nanorepro.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.6%	3.6%	16%	3.9%	-11%	6%	22%	-28%	-84%

Upcoming Earnings

Earnings Date

Fri, Jun 5 Today

News

Markets

Exchange	Ticker	Price	Quotes
Deutsche Börse Xetra (XETRA) MIC: XETR PRIMARY	NN6 ISIN: DE0006577109 Shares Out.: Shares Outstanding: 13.904M¹ Shares Float: 12.948M² TV: TradingView: XETR: NN6 SA: Stock Analysis: ETR: NN6 YF: Yahoo Finance: NN6.DE GF: Google Finance: FRA: NN6 BA: Barron's: NN6 MS: Morningstar: XETR: NN6	1.53 EUR	TV: TradingView: XETR: NN6 SA: Stock Analysis: ETR: NN6 YF: Yahoo Finance: NN6.DE GF: Google Finance: FRA: NN6 BA: Barron's: NN6 MS: Morningstar: XETR: NN6
Frankfurt Stock Exchange (FRA) MIC: XFRA	NN6 ISIN: DE0006577109 TV: TradingView: FWB: NN6 SA: Stock Analysis: FRA: NN6 YF: Yahoo Finance: NN6.F GF: Google Finance: FRA: NN6 BA: Barron's: NN6 MS: Morningstar: XFRA: NN6	1.53 EUR	TV: TradingView: FWB: NN6 SA: Stock Analysis: FRA: NN6 YF: Yahoo Finance: NN6.F GF: Google Finance: FRA: NN6 BA: Barron's: NN6 MS: Morningstar: XFRA: NN6

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About NanoRepro AG

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.

Similar Companies

Industry: Medical Care Facilities (Germany)

Name	Market Cap (USD) diff.	PE	Country
Fresenius SE & Co. KGaA XETRA: FRE	$26.65B 22.97B EUR 116K%	15.0	Germany
Fresenius Medical Care AG XETRA: FME	$12.1B 10.43B EUR 53K%	11.5	Germany
RHÖN-KLINIKUM Aktiengesellschaft XETRA: RHK	$954.95M 823.34M EUR 4K%	23.9	Germany
M1 Kliniken AG XETRA: M12	$352.08M 303.56M EUR 1K%	17.2	Germany
MEDICLIN Aktiengesellschaft XETRA: MED	$189.52M 163.4M EUR 725%	6.4	Germany
LIMES Schlosskliniken AG XETRA: LIK	$167.71M 144.6M EUR 630%	30.7	Germany

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.22B 852.82B AED 1M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 421K%	14.9	United States
Koninklijke Philips N.V. AMS: PHIA	$25.54B 22.02B EUR 111K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.47B 84.42B SAR 98K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 92K%	24.6	United States
IHH Healthcare Bhd. MYX: 5225	$19.4B 77.85B MYR 84K%	37.0	Malaysia

chevron_leftBack